ArticleOpen veterinary journal2026
Heart rate variability in horses with naturally occurring gastric ulcers: Response to omeprazole and sucralfate treatment.
Article in Open veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Equine gastric ulcer syndrome (EGUS) is the most common disease affecting the equine stomach. Heart rate variability (HRV) describes and quantifies the variability between consecutive heartbeats due to the neurohormonal regulation of the heart. It has been considered a non-invasive method to detect autonomic tone changes that can be influenced by pain and disease. Aim: This study aimed to assess the HRV indices in horses affected by EGUS submitted or not to treatment. Methods: A cohort of 45 mares underwent baseline gastroscopy (T0); 24/45 mares diagnosed with Equine Squamous Gastric Disease (ESGD) graded 2 out of 4 or greater were included and assigned to treated (T, Results: At T0, ESGD at least 2/4 score was diagnosed in all the horses included, while Equine Glandular Gastric Disease (EGGD) at least 1/4 score was diagnosed in 8/12 and 12/12 horses in the NT and T groups, respectively. No significant differences were observed in HRV indices within or between groups over time. The treatment significantly reduced ESGD scores ( Conclusion: Although HRV did not change significantly post-treatment, it appears to be a promising tool for assessing autonomic function in EGUS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.